Publications by authors named "Sandrine Hiret"

Claim this Profile
I
Implementation and challenges of prehabilitation in gastrointestinal oncology: A national cross-sectional survey in France.
Eva Ester Molina Beltran, Nora Dollet Nedellec, Marc Hilmi, Matthieu Delaye, Bruno Raynard, Sandrine Hiret

Clin Nutr ESPEN· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amivantamab in Participants With Advanced NSCLC and MET Exon 14 Skipping Mutations: Final Results From the CHRYSALIS Study.
Matthew G Krebs, Byoung Chul Cho, Sandrine Hiret, Ji-Youn Han, Ki Hyeong Lee

J Thorac Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progression-Free Survival Under Immune Checkpoint Inhibitors for Metastatic Non-Small-Cell Lung Cancer: A Retrospective Cohort Study.
Paul Boré, Margaux Geier, Loïc Campion, Jean-Luc Raoul, Ludovic Doucet, Sandrine Hiret

Oncol Ther· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting Transforming Growth Factor-β and Programmed Death-Ligand 1, Plus Chemotherapy in Patients With Stage IV NSCLC.
Christian Rolfo, Laurent Greillier, Remi Veillon, Firas Badin, Francois Ghiringhelli, Sandrine Hiret

JTO Clin Res Rep· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PIPAC in patients with peritoneal metastases from gastrointestinal tract (PIPOX01): An open label, non-comparative phase 1/2 dose escalation and expansion trial.
Frédéric Dumont, Vahan Kepenekian, Christophe Passot, Anne-Cécile Ezanno-Manasterski, Marc Pocard, Sandrine Hiret

Eur J Surg Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world overview of therapeutic strategies and prognosis of older patients with advanced or metastatic non-small cell lung cancer from the ESME database.
Mathilde Cabart, Loïc Mourey, David Pasquier, Sophie Schneider, Hervé Léna, Sandrine Hiret

J Geriatr Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Impact of TP53 Mutations in Metastatic Nonsquamous Non-small-cell Lung Cancer.
Laurent Mathiot, Benoit Nigen, Thomas Goronflot, Sandrine Hiret, Ludovic Doucet

Clin Lung Cancer· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pemigatinib for patients with previously treated, locally advanced or metastatic cholangiocarcinoma harboring FGFR2 fusions or rearrangements: A joint analysis of the French PEMI-BIL and Italian PEMI-REAL cohort studies.
Alessandro Parisi, Blandine Delaunay, Giada Pinterpe, Antoine Hollebecque, Jean Frederic Blanc, Sandrine Hiret

Eur J Cancer· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preliminary tolerance analysis of adjuvant chemotherapy in older patients after resection of stage III colon cancer from the PRODIGE 34-FFCD randomized trial.
Thomas Aparicio, Olivier Bouché, Pierre-Luc Etienne, Emilie Barbier, Laurent Mineur, Sandrine Hiret

Dig Liver Dis· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Efficacy of Dostarlimab in Patients With Recurrent/Advanced Non-small Cell Lung Cancer: Results from Cohort E of the Phase I GARNET Trial.
Victor Moreno, Desamparados Roda, Joanna Pikiel, Jose Trigo, Joaquim Bosch-Barrera, Sandrine Hiret

Clin Lung Cancer· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-1 Blockade in Solid Tumors with Defects in Polymerase Epsilon.
Benoit Rousseau, Ivan Bieche, Eric Pasmant, Nadim Hamzaoui, Nicolas Leulliot, Sandrine Hiret

Cancer Discov· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tiragolumab plus atezolizumab versus placebo plus atezolizumab as a first-line treatment for PD-L1-selected non-small-cell lung cancer (CITYSCAPE): primary and follow-up analyses of a randomised, double-blind, phase 2 study.
Byoung Chul Cho, Delvys Rodriguez Abreu, Maen Hussein, Manuel Cobo, Anjan J Patel, Sandrine Hiret

Lancet Oncol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival after cytoreductive surgery for peritoneal metastases in colorectal cancer patients: Does a history of resected liver metastases worsen the prognosis?
Frédéric Dumont, Simon Guénolé, Cécile Loaec, Charlotte Bourgin, Judith Raimbourg, Sandrine Hiret

Eur J Surg Oncol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Real-World Study of Patients with Advanced Non-squamous Non-small Cell Lung Cancer with EGFR Exon 20 Insertion: Clinical Characteristics and Outcomes.
Christos Chouaid, Thomas Filleron, Didier Debieuvre, Maurice Pérol, Nicolas Girard, Sandrine Hiret

Target Oncol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transient Vision Loss - A Rare Oxaliplatin-Induced Ophthalmologic Side Effect: A Report of Two Cases.
Loic Ah-Thiane, Jean-Luc Raoul, Sandrine Hiret, Hélène Senellart, Frédéric Dumont

Case Rep Oncol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I dose-escalation study of oxaliplatin delivered via a laparoscopic approach using pressurised intraperitoneal aerosol chemotherapy for advanced peritoneal metastases of gastrointestinal tract cancers.
Frédéric Dumont, Christophe Passot, Jean-Luc Raoul, Vahan Kepenekian, Bénédicte Lelièvre, Sandrine Hiret

Eur J Cancer· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized Phase II Trial Evaluating Treatment with EGFR-TKI Associated with Antiestrogen in Women with Nonsquamous Advanced-Stage NSCLC: IFCT-1003 LADIE Trial.
Julien Mazieres, Fabrice Barlesi, Isabelle Rouquette, Olivier Molinier, Benjamin Besse, Sandrine Hiret

Clin Cancer Res· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High Prevalence of Somatic Oncogenic Driver Alterations in Patients With NSCLC and Li-Fraumeni Syndrome.
Laura Mezquita, Maria Jové, Ernest Nadal, Maria Kfoury, Teresa Morán, Sandrine Hiret

J Thorac Oncol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Impact of Pretherapeutic FDG-PET in Localized Anal Cancer.
Maelle Le Thiec, Aude Testard, Ludovic Ferrer, Camille Guillerminet, Olivier Morel, Sandrine Hiret

Cancers (Basel)· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Weekly paclitaxel plus bevacizumab versus docetaxel as second- or third-line treatment in advanced non-squamous non-small-cell lung cancer: Results of the IFCT-1103 ULTIMATE study.
Alexis B Cortot, Clarisse Audigier-Valette, Olivier Molinier, Sylvestre Le Moulec, Fabrice Barlesi, Sandrine Hiret

Eur J Cancer· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intra-abdominal recurrence from colorectal carcinoma: Differences and similarities between local and peritoneal recurrence.
Frédéric Dumont, Solène Joseph, Gérard Lorimier, Valéria De Franco, Romuald Wernert, Sandrine Hiret

Surg Oncol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Significance of lymph node involvement in local recurrence of colorectal cancer.
Frédéric Dumont, Miguel A Muñoz, Valéria De Franco, Romuald Wernert, Valérie Verriele, Sandrine Hiret

J Surg Oncol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRAF Non-V600E Mutated Metastatic Colorectal Cancer in a Young Patient: Discussion from a Case Report.
Laure Moisset, Judith Raimbourg, Sandrine Hiret, Jonathan Dauve, Michèle Boisdron-Celle

Case Rep Oncol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rationale and Design of the IROCAS Study: Multicenter, International, Randomized Phase 3 Trial Comparing Adjuvant Modified (m) FOLFIRINOX to mFOLFOX6 in Patients With High-Risk Stage III (pT4 and/or N2) Colon Cancer-A UNICANCER GI-PRODIGE Trial.
Jaafar Bennouna, Thierry André, Loïc Campion, Sandrine Hiret, Laurent Miglianico

Clin Colorectal Cancer· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Continuation of Bevacizumab vs Cetuximab Plus Chemotherapy After First Progression in KRAS Wild-Type Metastatic Colorectal Cancer: The UNICANCER PRODIGE18 Randomized Clinical Trial.
Jaafar Bennouna, Sandrine Hiret, Aurelie Bertaut, Olivier Bouché, Gael Deplanque

JAMA Oncol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis